Document is current
Any future updates will be listed below
-
Authors
Veronese, Simone https://orcid.org/0000-0002-9555-7252
Bertocchi, Elisabetta https://orcid.org/0000-0002-9595-6384
Lissoni, Barbara
Rudà , Roberta https://orcid.org/0000-0001-9134-1537
Silvani, Antonio https://orcid.org/0000-0002-4791-1042
Simonetti, Giorgia https://orcid.org/0000-0002-0064-5509
Pisanello, Anna
Ieraci, Sonia
Salmaggi, Andrea https://orcid.org/0000-0001-6925-3434
Merli, Rossella
Verza, Marina
De Panfilis, Ludovica https://orcid.org/0000-0002-5509-7626
Solari, Alessandra https://orcid.org/0000-0001-9930-7579
Pace, Andrea https://orcid.org/0000-0002-9407-6916
- License Information
-
More Information
Article History
Received: 30 January 2023
Accepted: 13 February 2023
First Online: 21 February 2023
Declarations
:
: The research project was approved by the Ethics Committees the IRCCS-Regina Elena National Cancer Institute (ref. 1240/19); Fondazione IRCCS Istituto Neurologico Carlo Besta (ref. 65/18.09.2019); Azienda USL-IRCCS di Reggio Emilia (ref. 2020/0063420); ASST Papa Giovanni XXIII, Bergamo (ref. 219/19). All participants provided signed informed consent. They did not receive any financial compensation for their participation in the study.
: Dr. Solari reports grants from the Italian Multiple Sclerosis Foundation (FISM) and the European Academy of Neurology, during the conduct of the study; she serves as board member for Merck Serono and received personal fees from Almirall and Merck Serono, outside the submitted work. Dr. Rudà received honoraria for lectures or advisory boards from Bayer, Genenta, Novocure, and UCB. All the other authors have nothing to declare.
